Literature DB >> 21338319

Does mitochondrial DNA play a role in Parkinson's disease? A review of cybrid and other supportive evidence.

Russell H Swerdlow1.   

Abstract

SIGNIFICANCE: Mitochondria are currently believed to play an important role in the neurodysfunction and neurodegeneration that underlie Parkinson's disease (PD). RECENT ADVANCES: While it increasingly appears that mitochondrial dysfunction in PD can have different causes, it has been proposed that mitochondrial DNA (mtDNA) may account for or drive mitochondrial dysfunction in the majority of the cases. If correct, the responsible mtDNA signatures could represent acquired mutations, inherited mutations, or population-distributed polymorphisms. CRITICAL ISSUES AND FUTURE DIRECTIONS: This review discusses the case for mtDNA as a key mediator of PD, and especially focuses on data from studies of PD cytoplasmic hybrid (cybrid) cell lines.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21338319      PMCID: PMC3643260          DOI: 10.1089/ars.2011.3948

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  158 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  High frequency of mitochondrial complex I mutations in Parkinson's disease and aging.

Authors:  Rafal Smigrodzki; Janice Parks; W Davis Parker
Journal:  Neurobiol Aging       Date:  2004 Nov-Dec       Impact factor: 4.673

3.  Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family.

Authors:  R H Swerdlow; J K Parks; J N Davis; D S Cassarino; P A Trimmer; L J Currie; J Dougherty; W S Bridges; J P Bennett; G F Wooten; W D Parker
Journal:  Ann Neurol       Date:  1998-12       Impact factor: 10.422

4.  Maternal inheritance in Parkinson's disease.

Authors:  G F Wooten; L J Currie; J P Bennett; M B Harrison; J M Trugman; W D Parker
Journal:  Ann Neurol       Date:  1997-02       Impact factor: 10.422

5.  Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease.

Authors:  Y Mizuno; S Ohta; M Tanaka; S Takamiya; K Suzuki; T Sato; H Oya; T Ozawa; Y Kagawa
Journal:  Biochem Biophys Res Commun       Date:  1989-09-29       Impact factor: 3.575

6.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

7.  Mitochondrial oxidative phosphorylation defects in Parkinson's disease.

Authors:  J M Shoffner; R L Watts; J L Juncos; A Torroni; D C Wallace
Journal:  Ann Neurol       Date:  1991-09       Impact factor: 10.422

8.  Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson's disease.

Authors:  David K Simon; Michael T Lin; Leiya Zheng; Guang-Jun Liu; Colette H Ahn; Lauren M Kim; William M Mauck; Florence Twu; M Flint Beal; Donald R Johns
Journal:  Neurobiol Aging       Date:  2004-01       Impact factor: 4.673

9.  Cybrid models of Parkinson's disease show variable mitochondrial biogenesis and genotype-respiration relationships.

Authors:  Paula M Keeney; Lisa D Dunham; Caitlin K Quigley; Stephanie L Morton; Kristen E Bergquist; James P Bennett
Journal:  Exp Neurol       Date:  2009-10-06       Impact factor: 5.330

Review 10.  Mitochondrial DNA sequence variation and neurodegeneration.

Authors:  Michelangelo Mancuso; Massimiliano Filosto; Daniele Orsucci; Gabriele Siciliano
Journal:  Hum Genomics       Date:  2008-09       Impact factor: 4.639

View more
  16 in total

Review 1.  Stochastic modulations of the pace and patterns of ageing: impacts on quasi-stochastic distributions of multiple geriatric pathologies.

Authors:  George M Martin
Journal:  Mech Ageing Dev       Date:  2011-09-22       Impact factor: 5.432

2.  Metabolically induced heteroplasmy shifting and l-arginine treatment reduce the energetic defect in a neuronal-like model of MELAS.

Authors:  Valerie Desquiret-Dumas; Naig Gueguen; Magalie Barth; Arnaud Chevrollier; Saege Hancock; Douglas C Wallace; Patrizia Amati-Bonneau; Daniel Henrion; Dominique Bonneau; Pascal Reynier; Vincent Procaccio
Journal:  Biochim Biophys Acta       Date:  2012-01-28

Review 3.  The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects.

Authors:  Amica C Müller-Nedebock; Rebecca R Brennan; Marianne Venter; Ilse S Pienaar; Francois H van der Westhuizen; Joanna L Elson; Owen A Ross; Soraya Bardien
Journal:  Neurochem Int       Date:  2019-06-21       Impact factor: 3.921

Review 4.  Bioenergetic medicine.

Authors:  Russell H Swerdlow
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 5.  Bioenergetics and metabolism: a bench to bedside perspective.

Authors:  Russell H Swerdlow
Journal:  J Neurochem       Date:  2016-03-10       Impact factor: 5.372

Review 6.  Role and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.

Authors:  Russell H Swerdlow
Journal:  Curr Pharm Des       Date:  2011       Impact factor: 3.116

Review 7.  The delta-opioid receptor and Parkinson's disease.

Authors:  Jin-Zhong Huang; Yi Ren; Yuan Xu; Tao Chen; Terry C Xia; Zhuo-Ri Li; Jian-Nong Zhao; Fei Hua; Shi-Ying Sheng; Ying Xia
Journal:  CNS Neurosci Ther       Date:  2018-08-03       Impact factor: 5.243

8.  Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease.

Authors:  Michael H Yan; Xinglong Wang; Xiongwei Zhu
Journal:  Free Radic Biol Med       Date:  2012-11-29       Impact factor: 7.376

9.  Effect of one month duration ketogenic and non-ketogenic high fat diets on mouse brain bioenergetic infrastructure.

Authors:  J Eva Selfridge; Heather M Wilkins; Lezi E; Steven M Carl; Scott Koppel; Eric Funk; Timothy Fields; Jianghua Lu; Ee Phie Tang; Chad Slawson; WenFang Wang; Hao Zhu; Russell H Swerdlow
Journal:  J Bioenerg Biomembr       Date:  2014-08-08       Impact factor: 2.945

10.  Distinct effects of rotenone, 1-methyl-4-phenylpyridinium and 6-hydroxydopamine on cellular bioenergetics and cell death.

Authors:  Samantha Giordano; Jisun Lee; Victor M Darley-Usmar; Jianhua Zhang
Journal:  PLoS One       Date:  2012-09-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.